Education
About Us
Working with TipRanks
Follow Us
Vivani Medical (VANI)
NASDAQ:VANI
VANI Stock Chart & Stats
$1.28
-$0.02(-1.59%)
At close: 4:00 PM EST
$1.28
-$0.02(-1.59%)
Day’s Range― - ―
52-Week Range$0.91 - $1.92
Previous CloseN/A
Volume36.09K
Average Volume (3M)216.92K
Market Cap
$96.30M
Enterprise Value$88.33M
Total Cash (Recent Filing)$2.63M
Total Debt (Recent Filing)$18.29M
Price to Earnings (P/E)―
Beta1.38
Next Earnings
Mar 26, 2026EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding72,952,230
10 Day Avg. Volume237,036
30 Day Avg. Volume216,922
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.62
Price to Sales (P/S)0.00
P/FCF Ratio-2.99
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-455.32
Enterprise Value/Ebitda-3.36
Forecast
1Y Price Target
$4.00Price Target Upside212.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical Development InitiationAnalyst notes the company is preparing to start clinical development for NPM-139 in chronic weight management, a milestone that could validate the program if human trials confirm preclinical findings.
Industry ValidationRecent acquisitions of differentiated obesity assets by major pharmaceutical firms highlight strong buyer interest, which could increase perceived value for NPM-139 if clinical progress continues.
Preclinical EfficacyPreclinical studies showed approximately 20% weight loss maintained for six months in animals, supporting the potential for meaningful efficacy in patients.
Bears Say
Future Dilution RiskAlthough recent financing generated $15.7 million, continued development needs could require additional offerings that dilute existing shareholders.
Liquidity And Operating LossesReported net loss of $6.5 million and a cash balance of $4.0 million indicate constrained liquidity and raise the likelihood of seeking further funding to sustain operations.
Near-term Financing NeedThe company may need to raise additional capital within the next 12 months, a development that could pressure the stock and lead to dilution.
Vivani Medical News
VANI FAQ
What was Vivani Medical’s price range in the past 12 months?
Vivani Medical lowest stock price was $0.91 and its highest was $1.92 in the past 12 months.
What is Vivani Medical’s market cap?
Vivani Medical’s market cap is $96.30M.
When is Vivani Medical’s upcoming earnings report date?
Vivani Medical’s upcoming earnings report date is Mar 26, 2026 which is in 48 days.
How were Vivani Medical’s earnings last quarter?
Vivani Medical released its earnings results on Nov 13, 2025. The company reported -$0.11 earnings per share for the quarter, the consensus estimate of -$0.11 by $0.
Is Vivani Medical overvalued?
According to Wall Street analysts Vivani Medical’s price is currently Undervalued.
Does Vivani Medical pay dividends?
Vivani Medical does not currently pay dividends.
What is Vivani Medical’s EPS estimate?
Vivani Medical’s EPS estimate is -0.09.
How many shares outstanding does Vivani Medical have?
Vivani Medical has 72,952,230 shares outstanding.
What happened to Vivani Medical’s price movement after its last earnings report?
Vivani Medical reported an EPS of -$0.11 in its last earnings report, expectations of -$0.11. Following the earnings report the stock price went down -11.111%.
Which hedge fund is a major shareholder of Vivani Medical?
Currently, no hedge funds are holding shares in VANI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vivani Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (212.50% Upside)
$4.00 (212.50% Upside)
Insider Transactions
Bought Shares
Worth $8.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.6%
Last 30 Days ▲ 12.5%
Last 30 Days ▲ 12.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.12%
12-Months-Change
Fundamentals
Return on Equity
-265.02%
Trailing 12-Months
Asset Growth
-40.06%
Trailing 12-Months
Company Description
Vivani Medical
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
VANI Stock 12 Month Forecast
Average Price Target
$4.00
▲(212.50% Upside)
Technical Analysis
Ownership Overview
47.41% Insiders
1.97% Mutual Funds
1.84% Other Institutional Investors
46.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---